Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.
AuthorsHorsman, Michael R
Margison, Geoffrey P
Hendry, Jolyon H
AffiliationDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
MetadataShow full item record
AbstractPURPOSE: The International Atomic Energy Agency (IAEA) held a Technical Meeting of Consultants to (1) discuss a selection of relatively new agents, not those well-established in clinical practice, that operated through a variety of mechanisms to sensitize tumors to radiation and (2) to compare and contrast their tumor efficacy, normal tissue toxicity, and status of development regarding clinical application. The aim was to advise the IAEA as to which developing agent or class of agents would be worth promoting further, by supporting additional laboratory research or clinical trials, with the eventual goal of improving cancer control rates using radiotherapy, in developing countries in particular. RESULTS: The agents under discussion included a wide, but not complete, range of different types of drugs, and antibodies that interfered with molecules in cell signaling pathways. These were contrasted with new molecular antisense and gene therapy strategies. All the drugs discussed have previously been shown to act as tumor cell radiosensitizers or to kill hypoxic cells present in tumors. CONCLUSION: Specific recommendations were made for more preclinical studies with certain of the agents and for clinical trials that would be suitable for industrialized countries, as well as trials that were considered more appropriate for developing countries.
CitationTumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. 2006, 64 (2):551-61 Int. J. Radiat. Oncol. Biol. Phys.
JournalInternational Journal of Radiation Oncology, Biology, Physics
- Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
- Authors: Weinmann M, Welz S, Bamberg M
- Issue date: 2003 Sep
- [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
- Authors: Azria D, Larbouret C, Robert B, Culine S, Ychou M, Verrelle P, Dubois JB, Pèlegrin A
- Issue date: 2003 Nov
- Sulfoglycolipids as candidate antiangiogenic radiosensitizers.
- Authors: Miura M, Sakimoto I, Ohta K, Sugawara F, Sakaguchi K
- Issue date: 2007 Jan
- Radiation sensitization with redox modulators: a promising approach.
- Authors: Rosenberg A, Knox S
- Issue date: 2006 Feb 1
- NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
- Authors: Lawrence YR, Vikram B, Dignam JJ, Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ Jr, Bentzen SM, Okunieff P, Coleman CN, Dicker AP
- Issue date: 2013 Jan 2